角膜炎

Lam DS, Houang E, Fan DS, et al. Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye. 2002;16:608-618.

• 全文
• 摘要

Toshida H, Kogure N, Inoue N, et al. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007;33:70-73.

• 摘要

Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130:143-150.

• 摘要

Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;(1):CD002898.

• 全文
• 摘要

Guess S, Stone DU, Chodosh J, et al. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007;5:240-250.

• 摘要

Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012;37:654-660.

• 摘要

1.  Rhee DJ, Pyfer MF. The Wills eye manual. Baltimore: Lippincott, Williams & Wilkins, 1999.

2.  Sharma S. Keratitis. Biosci Rep. 2001;21:419-444.

• 摘要

3.  Erie JC, Nevitt MP, Hodge DO, et al. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol. 1993;111:1665-1671.

• 摘要

4.  Lam DS, Houang E, Fan DS, et al. Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye. 2002;16:608-618.

• 全文
• 摘要

5.  Basak SK, Basak S, Mohanta A, et al. Epidemiological and microbiological diagnosis of suppurative keratitis in gangetic West Bengal, Eastern India. Indian J Ophthalmol. 2005;53:17-22.

• 摘要

6.  Kinota S, Wong KW, Biswas J, et al. Changing patterns of infectious keratitis: overview of clinical and histopathologic features of keratitis due to Acanthamoeba or atypical Mycobacteria, and of infectious crystalline keratopathy. Indian J Ophthalmol. 1993;41:3-14.

• 全文
• 摘要

7.  Toshida H, Kogure N, Inoue N, et al. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007;33:70-73.

• 摘要

8.  Upadhyay MP, Karmacharya PC, Koirala S, et al. The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol. 2001;85:388-392.

• 摘要

9.  Bharathi MJ, Ramakrishnan R, Vasu S, et al. Aetiological diagnosis of microbial keratitis in South India: a study of 1618 cases. Indian J Med Microbiol. 2002;20:19-24.

• 全文
• 摘要

10.  McKibbin M, Isaacs JD, Morrell AJ. Incidence of corneal melting in association with systemic disease in the Yorkshire Region, 1995-7. Br J Ophthalmol. 1999;83:941-943.

• 全文
• 摘要

11.  Kaiser PK, Friedman NJ. The Massachusetts eye and ear infirmary illustrated manual of ophthalmology. New York: Elsevier Science, 2004.

12.  Agrawal V, Biswas J, Madhavan HN, et al. Current perspectives in infectious keratitis. Indian J Ophthalmol. 1994;42:171-192.

• 全文
• 摘要

13.  Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000;19:625-643.

• 摘要

14.  Mondino BJ. Inflammatory diseases of the peripheral cornea. Ophthalmology. 1988;95:463-472.

• 摘要

15.  Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007;26:701-706.

• 摘要

16.  Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113:109-116.

• 摘要

17.  Tauber J, Sainz de la Maza M, Hoang-Xuan T, et al. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990;9:66-73.

• 摘要

18.  Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014;(10):CD005430.

• 全文
• 摘要

19.  Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130:143-150.

• 摘要

20.  Lalitha P, Srinivasan M, Rajaraman R, et al. Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol. 2012;154:934-939.

• 摘要

21.  Garg P, Vazirani J. Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea? Expert Rev Ophthalmol. 2013;8:41-44.

22.  The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. Ophthalmology. 1997;104:1902-1909.

• 摘要

23.  Panda A, Ahuja R, Sastry SS. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Eye. 1999;13:744-777.

• 摘要

24.  Hanet MS, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Can J Ophthalmol. 2012;47:493-499.

• 摘要

25.  Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;(1):CD002898.

• 全文
• 摘要

26.  American Academy of Opthalmology Preferred Practice Pattern Committee. Herpes simplex virus epithelial keratitis - PPP Clinical Question - 2013. June 2013. http://www.aao.org/ (last accessed 17 Aug 2016).

• 全文

27.  Guess S, Stone DU, Chodosh J, et al. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007;5:240-250.

• 摘要

28.  American Academy of Opthalmology; White ML, Chodosh J. Herpes simplex virus keratitis: a treatment guideline. June 2014. http://www.aao.org/ (last accessed 17 Aug 2016).

• 全文

29.  Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1871-1882.

• 摘要

30.  Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012;37:654-660.

• 摘要

31.  FlorCruz NV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database Syst Rev. 2015;(4):CD004241.

• 全文
• 摘要

32.  Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92:871-878.

• 摘要

33.  Alkharashi M, Lindsley K, Law HA, et al. Medical interventions for acanthamoeba keratitis. Cochrane Database Syst Rev. 2015;(2):CD010792.

• 全文
• 摘要

34.  Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. Cornea. 2010;29:1066-1068.

• 全文
• 摘要

35.  Cardine S, Bourcier T, Chaumeil C, et al. Clinical management and prognosis in Acanthamoeba keratitis: a retrospective study of 25 cases [in French]. J Fr Ophtalmol. 2002;25:1007-1013.

• 摘要

36.  Bang S, Edell E, Eghrari AO, et al. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Am J Ophthalmol. 2010;149:66-69.

• 摘要

37.  American Academy of Opthalmology Cornea/External Disease PPP Panel. Bacterial keratitis: preferred practice pattern guidelines. October 2013. http://www.aao.org/ (last accessed 9 December 2015).

• 全文

38.  Ti SE, Scott JA, Janardhanan P, et al. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol. 2007;143:755-762.

• 摘要

39.  Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens. 2006;32:267-271.

• 摘要

40.  Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology. 2005;112:888-895.

• 摘要

41.  Branco BC, Gaudio PA, Margolis TP. Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty. Br J Ophthalmol. 2004;88:1285-1288.

• 摘要